Trial Diversity in Action
Tigerlily Foundation works with the leaders in biotechnology to build trust, transparency and transformation as it pertains to health equity and eliminating barriers to clinical trials. As a trusted partner to patients of color, and led by a Black, female, triple negative (TNBC) breast cancer survivor, who has experienced many of the disparities she works to end; and who has grown an organization from her lived experience while undergoing chemotherapy, Tigerlily Foundation is a leader in diversity and health equity, working to change the way we talk about, think about, develop and deliver innovative therapies to patients of diverse populations. The below list is representative of some of the key trusted partners we work with as allies. With more than 12,000 people having taken our #InclusionPledge and 120+ organizational commitments, we are committed to driving change and innovation in clinical trials.
Bristol Myers Squibb Foundation
Tigerlily participates as a thought leader with some of the leading Contract Research Organizations (CROs) in the world, working to curate solutions to ensure diversity in clinical trials, and representing diverse patient perspectives and needs to overcome barriers in clinical trials.